JP2023532732A5 - - Google Patents
Info
- Publication number
- JP2023532732A5 JP2023532732A5 JP2022581569A JP2022581569A JP2023532732A5 JP 2023532732 A5 JP2023532732 A5 JP 2023532732A5 JP 2022581569 A JP2022581569 A JP 2022581569A JP 2022581569 A JP2022581569 A JP 2022581569A JP 2023532732 A5 JP2023532732 A5 JP 2023532732A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- enpp1
- enpp3
- polypeptide
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047865P | 2020-07-02 | 2020-07-02 | |
| US202063047877P | 2020-07-02 | 2020-07-02 | |
| US202063047848P | 2020-07-02 | 2020-07-02 | |
| US202063047793P | 2020-07-02 | 2020-07-02 | |
| US63/047,848 | 2020-07-02 | ||
| US63/047,793 | 2020-07-02 | ||
| US63/047,865 | 2020-07-02 | ||
| US63/047,877 | 2020-07-02 | ||
| PCT/US2021/040356 WO2022006545A2 (en) | 2020-07-02 | 2021-07-02 | Compositions and methods for treating allograft vasculopathy, moyamoya disease, moyamoya syndrome and intimal proliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532732A JP2023532732A (ja) | 2023-07-31 |
| JP2023532732A5 true JP2023532732A5 (enExample) | 2024-07-09 |
Family
ID=79317840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581569A Pending JP2023532732A (ja) | 2020-07-02 | 2021-07-02 | 同種移植片血管障害、モヤモヤ病、モヤモヤ症候群、及び内膜増殖を治療するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240016951A1 (enExample) |
| EP (1) | EP4175657A4 (enExample) |
| JP (1) | JP2023532732A (enExample) |
| KR (1) | KR20230048020A (enExample) |
| CN (1) | CN116322742A (enExample) |
| AU (1) | AU2021300261A1 (enExample) |
| BR (1) | BR112022026907A2 (enExample) |
| CA (1) | CA3184349A1 (enExample) |
| CO (1) | CO2023000754A2 (enExample) |
| IL (1) | IL299503A (enExample) |
| MX (1) | MX2023000247A (enExample) |
| TW (1) | TW202216186A (enExample) |
| WO (1) | WO2022006545A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022091048A1 (en) | 2020-10-30 | 2022-05-05 | Integral Biosciences Private Limited | Ectonucleotide pyrophosphatase-phosphodiesterase-1 (enpp1) inhibitors and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2545080B1 (en) * | 2010-03-12 | 2017-05-10 | Alexion Pharmaceuticals, Inc. | Npp1 fusion proteins |
| PL2956163T3 (pl) * | 2013-02-13 | 2025-04-14 | Yale University | Kompozycje do leczenia patologicznego zwapnienia i kostnienia |
| EP3377105A4 (en) * | 2015-11-20 | 2019-04-24 | Yale University | COMPOSITIONS FOR THE TREATMENT OF ECTOPIC CALIBRATION DISORDERS AND METHODS THEREWITH |
| EP3471747A1 (en) * | 2016-06-16 | 2019-04-24 | Alexion Pharmaceuticals, Inc. | Methods of treating myointimal proliferation |
| WO2018119328A1 (en) * | 2016-12-22 | 2018-06-28 | Mavupharma, Inc. | Phosphodiesterase inhibitors and methods of microbial treatment |
-
2021
- 2021-07-02 CA CA3184349A patent/CA3184349A1/en active Pending
- 2021-07-02 IL IL299503A patent/IL299503A/en unknown
- 2021-07-02 AU AU2021300261A patent/AU2021300261A1/en active Pending
- 2021-07-02 WO PCT/US2021/040356 patent/WO2022006545A2/en not_active Ceased
- 2021-07-02 MX MX2023000247A patent/MX2023000247A/es unknown
- 2021-07-02 TW TW110124480A patent/TW202216186A/zh unknown
- 2021-07-02 EP EP21831757.6A patent/EP4175657A4/en active Pending
- 2021-07-02 BR BR112022026907A patent/BR112022026907A2/pt unknown
- 2021-07-02 CN CN202180055861.8A patent/CN116322742A/zh active Pending
- 2021-07-02 JP JP2022581569A patent/JP2023532732A/ja active Pending
- 2021-07-02 KR KR1020237003831A patent/KR20230048020A/ko active Pending
-
2022
- 2022-12-30 US US18/148,888 patent/US20240016951A1/en active Pending
-
2023
- 2023-01-24 CO CONC2023/0000754A patent/CO2023000754A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007342674B2 (en) | Polypeptide inhibitors of HSP27 kinase and uses therefor | |
| EA006036B1 (ru) | Фармацевтическая комбинация для профилактики и лечения повреждений, связанных с дефицитом артериального кровотока | |
| JPH0692318B2 (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| JP2024543209A5 (enExample) | ||
| Iwatsuki et al. | Current status of hepatic transplantation | |
| JP2024544057A5 (enExample) | ||
| US20090275732A1 (en) | Agent for improving circulatory disorder | |
| Serrano et al. | Familial Mediterranean fever and acute myocardial infarction secondary to coronary vasculitis | |
| JP2007508823A (ja) | 新規な熱ショックタンパク質２０関連ポリペプチドおよびその使用 | |
| JP2024534496A5 (enExample) | ||
| Lee et al. | ABO-incompatible living donor liver transplantation with a simplified desensitization and immunosuppression protocol: a single-center retrospective study | |
| Groff et al. | Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy | |
| MATsUNAMI et al. | A case of familial amyloid polyneuropathy treated with partial liver transplantation using a graft from a living related donor | |
| Yasuda et al. | The changes in treatment strategies in ABOi living donor liver transplantation for acute liver failure | |
| JP2995860B2 (ja) | 新規ペプチド | |
| WO2016162369A1 (fr) | Nouvelle utilisation du facteur von willebrand | |
| US20100172909A1 (en) | Cerebral edema suppressant | |
| JP2023527364A5 (enExample) | ||
| CN100508749C (zh) | 器官保存液及其制法和应用 | |
| CA3184349A1 (en) | Compositions and methods for treating allograft vasculopathy, moyamoya disease, moyamoya syndrome and intimal proliferation | |
| CN115887620B (zh) | Csf1-cd47在制备移植早期免疫排斥抑制剂中的应用 | |
| JPH10194986A (ja) | 移植肝機能改善・再生促進剤 | |
| WO2001087324A1 (en) | Compositions and methods for promoting immunosuppression | |
| JP3691533B2 (ja) | 抗動脈硬化ペプチド | |
| Kimura et al. | Surgical treatment of a patient with progressive thrombosis of the renal artery associated with neurofibromatosis |